{
  "meta": {
    "title": "Anti-Hypertensives_Vasodilators_Drugs_For_Dyslipidemia_Antianginal_Drugs",
    "url": "https://brainandscalpel.vercel.app/anti-hypertensives-vasodilators-drugs-for-dyslipidemia-antianginal-drugs-1e1b0334.html",
    "scrapedAt": "2025-11-30T08:50:46.912Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Epinephrine</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Dopamine</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemodialysis</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucagon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 72-year-old woman is found unresponsive at home. Her Pulse is 30/min and blood pressure is 70/30 mmHg. ECG demonstrates features as shown below in a figure. Her son believes she may have ingested too many of the metoprolol pills which she takes for hypertension. Which of the following is the best intervention?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241221442654f0-9151-4e71-be91-df8b344177b0.jpg\"></span></p>",
      "unique_key": "DT1293072",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293072,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>This patient has <strong><em>signs and symptoms of beta blocker overdose</em></strong> including altered <strong><em>mental status, bradycardia, and low blood pressure</em></strong></li>\r\n<li><strong><em><u>Adverse effects of beta blockers</u></em></strong></li>\r\n<li><strong><em><u>Mnemonic [BALD FISH]</u></em></strong>\r\n<ul>\r\n<li><strong>B</strong>ronchoconstriction</li>\r\n<li><strong>B</strong>radycardia</li>\r\n<li><strong>A</strong>rrhythmia</li>\r\n<li><strong>L</strong>ethargy</li>\r\n<li><strong>D</strong>isturbed glucose metabolism</li>\r\n<li><strong>F</strong>atigue</li>\r\n<li><strong>I</strong>nsomnia</li>\r\n<li><strong>S</strong>exual dysfunction</li>\r\n<li><strong>H</strong>ypotension</li>\r\n</ul>\r\n</li>\r\n<li><strong><em>Glucagon is the first line therapy</em></strong> in this setting.</li>\r\n<li>Glucagon <strong><em>activates the enzyme adenylate cyclase</em></strong> at a different site from beta agonists.</li>\r\n<li>Glucagon has the <strong><em>same effects on the heart as beta stimulation but its action is not impaired by beta blockers. This <u>reverses bradycardia, raises cardiac output and raises blood pressure.</u></em></strong></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501221e4b5402-e3a8-4ec4-b684-0267daa2b53b.jpg\">\r\n<p><strong>Option A &amp; B</strong>: Agents <em>which function as beta-agonists including epinephrine and dopamine are rarely used in beta-blocker poisoning</em>.</p>\r\n<p><strong>Option C</strong>: <em>Hemodialysis has only a small role</em> in beta-blocker overdose. It is not a first line intervention.</p>\r\n<p>It is <strong><em>effective only for the removal of some beta blockers like atenolol and nadolol</em></strong>. Hemodialysis <strong><em>does not remove metoprolol and propranolol</em></strong>.</p>\r\n<p><strong>Key takeaway:</strong></p>\r\n<ul>\r\n<li>Glucagon may be used to stimulate the heart in &beta; adrenergic blocker treated patients.</li>\r\n</ul>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Valsartan</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrochlorothiazide</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Amlodipine</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Spironolactone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 53-year-old man was brought to the medicine department for evaluation of his hypertension. He has a history of having chronic kidney disease related to IgA nephropathy. Blood pressure is 170/96 mmHg on serial measurements. Serum creatinine is 3.2 mg/dl and potassium is 6.7 meEq/L. Which of the following drugs is most appropriate for the treatment of this man's hypertension?</span></p>",
      "unique_key": "DT1293074",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293074,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>This patient has <strong><em>hypertension in the setting of chronic kidney disease and hyperkalemia</em></strong>. Amlodipine is the safest drug in this regard from above options.</p>\r\n<p><strong><em>Amlodipine is a dihydropyridine calcium channel blocker. It has no major adverse effects on renal function or potassium.</em></strong></p>\r\n<p>The major side effect is <strong><em>lower extremity edema.</em></strong></p>\r\n<p><strong><em><u>Advantages of CCBs as an Anti-hypertensive agent are:</u></em></strong></p>\r\n<ol>\r\n<li><strong><em> Do not compromise haemodynamics </em></strong></li>\r\n<li><strong><em> No sedation or other CNS effects</em></strong></li>\r\n<li><strong><em> Not contraindicated in asthma, angina (especially variant) and PVD patients </em></strong></li>\r\n<li><strong><em> Are particularly effective in elderly patients, black races and low renin hypertensives.</em></strong></li>\r\n<li><strong><em> Do not affect male sexual function.</em></strong></li>\r\n<li><strong><em> No deleterious effect on plasma lipid profile, uric acid level and electrolyte balance.</em></strong></li>\r\n<li><strong><em> Shown to have no/minimal effect on quality of life.</em></strong></li>\r\n<li><strong><em> No adverse foetal effects; can be used during pregnancy</em></strong></li>\r\n</ol>\r\n<p><u>The long-acting DHPs are next to ACE inhibitors in reducing albuminuria and slowing disease progression in hypertensive/diabetic nephropathy</u></p>\r\n<p><strong>Option A</strong>: Valsartan is an angiotensin receptor blocker. It <strong><em>reduces the glomerular filtration rate (GFR) through vasodilation of the efferent arteriole</em></strong>. These drugs are generally <u>avoided in advanced renal failure for this reason</u>.</p>\r\n<p>It may also <strong><em>increase potassium levels</em></strong> through inhibition of aldosterone release from the adrenal glands.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241221c8114754-3b15-46b5-b438-4ada5910efc9.jpg\">\r\n<p><strong>Option B</strong>: Hydrochlorothiazide is a thiazide diuretic. This <strong><em>drug will reduce the effective circulating volume and lower GFR thereby worsening renal function</em></strong>.</p>\r\n<p><strong>Option D</strong>: <strong><em>Spironolactone is a potassium sparing diuretic</em></strong>. Spironolactone also <strong><em>raises serum potassium which could be life-threatening in this man who already has hyperkalemia</em></strong>.</p>\r\n<p><strong>Key takeaway:</strong></p>\r\n<ul>\r\n<li><strong><em>The long-acting DHPs are next to ACE inhibitors in reducing albuminuria and slowing disease progression in hypertensive/diabetic nephropathy</em></strong></li>\r\n</ul>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Heart failure</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoalbuminemia</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal failure</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevated capillary hydrostatic pressure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 61-year-old man is evaluated for hypertension. Blood pressure is around 170/86 mmHg on multiple measurements. He is prescribed amlodipine. At follow-up one month later, his blood pressure is 138/78 mmHg. But he had developed pitting lower extremity edema. Which of the following is the most likely cause of his edema?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241221efacbcb7-5f8e-4023-b6f4-e219daaa3f33.jpg\"></span></p>",
      "unique_key": "DT1293075",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293075,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong><em>Edema is a common adverse effect of dihydropyridine calcium channel blocks like amlodipine. </em></strong></li>\r\n<li>These drugs <strong><em>block calcium channels in vascular smooth muscle</em></strong> leading to a fall in blood pressure.</li>\r\n<li><strong><em>Peripheral edema may occur in patients with Ca2+ channel blockers</em></strong> but is not the result of generalized fluid retention; rather, it most <strong><em>likely results from increased hydrostatic pressure in the lower extremities owing to precapillary dilation and reflex postcapillary constriction</em></strong></li>\r\n<li>This <strong><em>raises capillary hydrostatic pressure, causing edema</em></strong>.</li>\r\n</ul>\r\n<p><strong>Options A, B, C </strong>: Heart failure, hypoalbuminemia, renal failure, may all cause pitting edema. None of these is likely in this patient as physical examination of this patient have no complaints other than edema.</p>\r\n<p><strong>Key takeaway:</strong></p>\r\n<ul>\r\n<li><strong><em>Pitting lower extremity edema is a common adverse effect of dihydropyridine calcium channel blocks like amlodipine.</em></strong></li>\r\n</ul>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Uremia</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydralazine</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Clonidine</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Fenoldopam</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old man presents to medicine OPD for an evaluation of feeling sleepiness. He reports daytime sleepiness for the past one month that interferes with his ability to work. He has a history of chronic kidney disease with a serum creatinine level of 3.2mg/dl. He has refractory hypertension for which he takes four medications. Which of the following may be the cause of his somnolence?</span></p>",
      "unique_key": "DT1293076",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293076,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong><em>Somnolence is a common adverse effect of the anti-hypertensive drug clonidine</em></strong>.</li>\r\n<li>This drug is an <strong><em>alpha-2 agonist which decreases norepinephrine release. In the periphery, this causes a fall in adrenergic tone which lowers blood pressure.</em></strong></li>\r\n<li><strong><em>Excessive sleepiness is a common complaint of patients</em></strong> taking this drug.</li>\r\n<li>Clonidine is sometimes used as a therapy for insomnia in children</li>\r\n</ul>\r\n<p><strong><em><u>Adverse effects of</u></em></strong><strong><u> clonidine</u></strong></p>\r\n<ul>\r\n<li><strong><em>Sedation</em></strong><em>, mental depression, disturbed sleep; <strong>dryness of mouth, nose and eyes, constipation </strong></em></li>\r\n<li><strong><em>Impotence, salt and water retention, bradycardia</em></strong><em>.</em></li>\r\n<li><strong><em>Postural hypotension </em></strong></li>\r\n<li><em>On sudden withdrawal -- &gt; <strong>Alarming rise in BP, in excess of pretreatment level, with tachycardia, restlessness, anxiety, sweating, headache, nausea and vomiting</strong></em></li>\r\n</ul>\r\n<p><strong>Option A</strong>: <strong><em>Uremia may lead to confusion and fatigue</em></strong></p>\r\n<p><strong>Option</strong> <strong>B</strong>: Hydralazine is a <u>direct vasodilator</u>, Adverse <strong><em>effects include reflex tachycardia and drug-induced lupus</em></strong>. It is not associated with somnolence.</p>\r\n<p><strong>Option</strong> <strong>D</strong>: <strong><em>Fenoldopam is an intravenous drug used in hypertensive urgency and emergency.</em></strong> It is a dopamine agonist and, like many dopamine agonists, it is <u>stimulatory, It can cause anxiety and insomnia.</u></p>\r\n<p><strong>Key takeaway:</strong></p>\r\n<ul>\r\n<li><strong><em>Excessive sleepiness is a common complaint of patients</em></strong> taking this drug along with <strong><em>Sedation</em></strong><em>, mental depression, disturbed sleep.</em></li>\r\n</ul>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Aliskiren</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Ramipril</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Losartan</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Spironolactone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drug acts at the site marked by an arrow as shown in the diagram?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241221ecc3cf60-f5dd-4bea-85bb-d0504f5d0567.jpg\"></span></p>",
      "unique_key": "DT1293078",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293078,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><u>Inhibition of renin-angiotensin system</u></strong></p>\r\n<p>This can be achieved by:</p>\r\n<ol>\r\n<li><strong><em>Sympathetic blockers</em></strong> (&beta; blockers, adrenergic neurone blockers, central sympatholytics)- decrease renin release.</li>\r\n<li><strong><em>Direct renin inhibitors</em></strong> (DRIs, e.g. aliskiren): block renin action-interfere with generation of Ang I from angiotensinogen (<strong><em>rate limiting step).</em></strong></li>\r\n<li><strong><em>Angiotensin converting enzyme (ACE)</em></strong> inhibitors (e.g. <strong><em>captopril, Ramipril</em></strong>)-<strong><em>prevent generation of the active principle Angiotensin II from Angiotensin I</em></strong></li>\r\n<li><strong><em>Angiotensin receptor blockers</em></strong> (ARBs, e.g. losartan)-antagonise the action of Angiotensin II on target cells.</li>\r\n<li><strong><em>Aldosterone antagonists</em></strong> (e.g. spironolactone)- block mineralocorticoid receptors.</li>\r\n</ol>\r\n<p><strong><u>Different agents causing Inhibition of renin-angiotensin aldosterone system(RAAS)</u></strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412213c3d4b0d-3e61-4f60-8219-f06440ac9b5d.jpg\">\r\n<p><strong>Key takeaway:</strong></p>\r\n<ul>\r\n<li><strong><em>Angiotensin converting enzyme (ACE)</em></strong> inhibitors (e.g. <strong><em>captopril, Ramipril</em></strong>)-<strong><em>prevent generation of the active principle Angiotensin II from Angiotensin I</em></strong></li>\r\n</ul>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase of lipid synthesis by adipose tissue</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Down regulation of low-density lipoprotein (LDL) receptors in the liver</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition HMG-CoA reductase activity in the liver</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulation of lipoprotein lipase synthesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24 year old woman suffering from familial hypertriglyceridemia was screened with a blood lipid profile during a routine visit. Relevant laboratory test results were total cholesterol 170 mg/dL, triglycerides 1230 mg/dL. A suitable lipid-lowering drug was prescribed by her physician. Which of the following is the most likely the mechanism of action of that prescribed drug in the reduction of triglycerides?</span></p>",
      "unique_key": "DT1293084",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293084,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>The <strong><em>prescribed drug was most likely a fibrate.</em></strong></li>\r\n<li>The fibrates <strong><em>primarily activate lipoprotein lipase</em></strong> which is a key enzyme in the degradation of VLDL resulting in lowering of circulating triglycerides.</li>\r\n<li>This <strong><em>effect is exerted through nuclear <u>peroxisome proliferator-activated </u></em></strong><strong><em><u>receptor &alpha; (PPAR&alpha;)</u></em></strong><strong><em> that is a gene transcription regulating receptor expressed in liver, fat and muscles.</em></strong></li>\r\n</ul>\r\n<p><strong><u>Activation of PPAR&alpha; </u></strong></p>\r\n<ul>\r\n<li><strong><em>Enhances lipoprotein lipase synthesis and fatty acid oxidation. </em></strong></li>\r\n<li><strong><em>Mediate enhanced LDL receptor expression in liver</em></strong></li>\r\n<li>Fibrates decrease hepatic TG synthesis as well.</li>\r\n</ul>\r\n<p><strong><em>Drugs in this class primarily </em></strong></p>\r\n<ul>\r\n<li><strong><em>Lower TG levels by 20-50%, </em></strong></li>\r\n<li><strong><em>10-15% decrease in LDL-CH</em></strong></li>\r\n<li><strong><em>10-15% increase in HDL-CH.</em></strong></li>\r\n</ul>\r\n<p><strong><u>Summary of Anti-Dyslipidemic drugs</u></strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250122d6ea9868-5a43-4be9-bab1-0211802e91ec.jpg\">\r\n<p><strong>Key takeaway:</strong></p>\r\n<ul>\r\n<li>The fibrates <strong><em>primarily activate lipoprotein lipase</em></strong> which is a key enzyme in the degradation of VLDL resulting in lowering of circulating triglycerides.</li>\r\n</ul>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Ezetimibe</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Gemfibrozil</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Niacin</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Simvastatin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old woman presents to her primary care physician with complaints of muscle pain, cramping, and weakness in her legs. Her symptoms started shortly after starting a new medication for the management of hyperlip idemia. Laboratory results are positive for an elevated serum creatine phosphokinase. After further discussion, the patient reveals that she consumes grapefruit juice on daily basis. Which of the following drugs most likely caused this patient presentation?</span></p>",
      "unique_key": "DT1293085",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293085,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><em><u>Adverse drug reactions of statins</u></em></strong></p>\r\n<ul>\r\n<li><strong><em>Gastrointestinal complaints </em></strong></li>\r\n<li><strong><em>Headache </em></strong></li>\r\n<li><strong><em>Rashes and sleep disturbances are</em></strong></li>\r\n<li><strong><em>Rise in serum transaminase (Monitoring of liver function is recommended)</em></strong></li>\r\n<li><strong><em>Muscle aches are the commonest (10%) side effect</em></strong>. Rise in creatine phosphokinase<em> (CPK) levels occurs infrequently.</em></li>\r\n<li><strong><em>Myopathy &amp; rhabdomyolysis is the only serious reaction (rare</em></strong>)\r\n<ul>\r\n<li><strong><em>Myopathy and liver injury is more common when nicotinic acid/gemfibrozil </em></strong>or <strong><em><u>CYP3A4 inhibitor</u>-ketoconazole/ <u>grape fruit juice</u>/ erythromycin/ cyclosporine/HIV protease inhibitor is given -*concurrently.</em></strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><u>Fenofibrate <strong>interferes the least</strong> with statin uptake/metabolism and should be preferred for combining with them.</u></p>\r\n<p><strong>Option A: </strong>No specific adverse effect, except <strong><em>reversible hepatic dysfunction and rarely myositis </em></strong>has been noted with ezetimibe.</p>\r\n<p><strong>Option B: <em>Epigastric distress, loose motions. Skin rashes, body ache, eosinophilia, impotence, headache and blurred vision. </em></strong><u>Gemfibrozil + statin increases risk of myopathy and they should not be combined</u></p>\r\n<p><strong>Option C: </strong>Nicotinic acid is a cutaneous vasodilator: marked flushing, heat and itching (especially in the blush area) occur after every dose.</p>\r\n<ul>\r\n<li>Dyspepsia is very common; vomiting and diarrhoea</li>\r\n<li>Dryness and hyperpigmentation of skin can</li>\r\n<li>Liver dysfunction and jaundice.</li>\r\n</ul>\r\n<p><strong>Key takeaway:</strong></p>\r\n<ul>\r\n<li><strong><em>Muscle aches are the commonest (10%) side effect</em></strong>. Rise in creatine phosphokinase<em> (CPK) levels occurs infrequently.</em></li>\r\n</ul>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Stop taking the levothyroxine as it can interact with cholestyramine</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Take levothyroxine 1 hour before cholestyramine on an empty stomach</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Switch cholestyramine to colesevelam as this eliminates the interaction</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Switch cholestyramine to colestipol as this eliminates the interaction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old female brought to the medicine department with a history of hyperlipidemia and hypothyroidism. She was prescribed cholestyramine and levothyroxine by her physician. What advice would her physician should give this patient to avoid a drug interaction between her cholestyramine and levothyroxine?</span></p>",
      "unique_key": "DT1293086",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293086,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong><em>Cholestyramine and the bile acid sequestrants can bind several medications, causing decreased absorption of medications such as levothyroxine.</em></strong></li>\r\n<li><strong><em>They are neither digested nor absorbed in the gut: <u>bind bile acids in the intestine interrupting their enterohepatic circulation.</u></em></strong></li>\r\n<li><strong><em>Administration of <u>levothyroxine 1 hour before or 4 to 6 hours after cholestyramine</u> can help to avoid this interaction.</em></strong></li>\r\n<li>Oral <em>bioavailability of l-thyroxine is ~ 75%,</em></li>\r\n<li>It should be administered in <strong><em>empty stomach to avoid interference by food.</em></strong></li>\r\n<li>Sucralfate, <em>iron, calcium and proton pump inhibitors also reduce l-thyroxine absorption.</em></li>\r\n<li><em>CYP3A4 inducers like rifampin, phenytoin and carbamazepine accelerate metabolism of T4; dose of l-thyroxine may need enhancement</em></li>\r\n</ul>\r\n<p><strong>Key takeaway:</strong></p>\r\n<ul>\r\n<li><strong><em>Cholestyramine and the bile acid sequestrants can bind several medications, causing decreased absorption of medications such as levothyroxine.</em></strong></li>\r\n</ul>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Lovastatin</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholestyramine</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Ezetimibe</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Niacin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old man was found to have total cholesterol of 380 mg/dL and triglycerides of 230 mg/dL despite 3 months of a diet low in saturated fat. The man had been suffering from hemophilia since birth and from external hemorrhoids for 2 years. An antihyperlipidemic therapy was prescribed. Which of the following drugs would be contraindicated in this patient?</span></p>",
      "unique_key": "DT1293087",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293087,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong><em>Cholestyramine can cause severe <u>constipation and is therefore contraindicated in patients with hemorrhoids. </u></em></strong></li>\r\n<li><strong><em>In addition, the drug is contraindicated in patients with any coagulation defect because it <u>decreases the intestinal absorption of vitamin K.</u> </em></strong></li>\r\n</ul>\r\n<p><strong><u>Bile Acid Sequestrants (Resins)</u></strong></p>\r\n<ul>\r\n<li><strong>Cholestyramine </strong></li>\r\n<li><strong>Colestipol</strong></li>\r\n<li><strong>Colesevelam</strong></li>\r\n</ul>\r\n<p>They <strong><em>are neither digested nor absorbed in the gut: bind bile acids in the intestine interrupting their enterohepatic circulation.</em></strong></p>\r\n<p><strong><em>Faecal excretion of bile salts and CH (which is absorbed with the help of bile salts) is increased. This <u>indirectly leads to enhanced hepatic metabolism of Cholesterol to bile acids.</u></em></strong></p>\r\n<p>They are</p>\r\n<ul>\r\n<li><em>Unpalatable, </em></li>\r\n<li><em>Inconvenient, required in large doses </em></li>\r\n<li><em>Cause <strong>flatulence and other gastro-intestinal Symptoms</strong>, </em></li>\r\n<li><strong><em>Interfere with absorption of many drugs and have poor patient acceptability.</em></strong></li>\r\n</ul>\r\n<p><strong>Key takeaway:</strong></p>\r\n<ul>\r\n<li><strong><em>Cholestyramine can cause severe constipation and is therefore contraindicated in patients with hemorrhoids. </em></strong></li>\r\n</ul>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer aspirin 30 minutes prior to taking niacin</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer aspirin 30 minutes after taking niacin</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase the dose of niacin</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Change the sustained-release niacin to immediate-release niacin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old man was started on sustained-release niacin 2 weeks ago. He reports uncomfortable flushing and itchiness that he thinks is related to the niacin. Which of the following can help manage this adverse effect of niacin therapy?</span></p>",
      "unique_key": "DT1293088",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293088,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong><em>Flushing associated with niacin is prostaglandin mediated</em></strong>; therefore, use of aspirin (a prostaglandin inhibitor) can help to minimize this adverse effect.</li>\r\n<li>It must be <strong><em>administered 30 minutes before</em></strong> the dose of the niacin</li>\r\n</ul>\r\n<p><strong><em><u>Adverse drug reactions of Nicotine</u></em></strong></p>\r\n<ol>\r\n<li><strong><u>Nicotinic acid is a cutaneous vasodilator: marked flushing, heat and itching</u></strong>\r\n<ul>\r\n<li>This is associated with <strong><em>release of PGD2</em></strong> in the skin,</li>\r\n<li>Minimized by <strong><em>starting with a low dose taken with meals</em></strong></li>\r\n<li><strong><em>Gradually increasing as tolerance develops</em></strong></li>\r\n<li>Use of <strong><em>sustained release (SR/ER) tablet</em></strong> also subdues flushing.</li>\r\n<li><strong><em>Aspirin taken before niacin substantially attenuates flushing by inhibiting PG synthesis.</em></strong></li>\r\n</ul>\r\n</li>\r\n<li><strong><em>Laropiprant</em></strong><em>, </em>a <strong><u>prostanoid receptor inhibitor</u></strong>, is a specific <strong><em>antiflushing drug that has been combined with nicotinic acid to minimize flushing</em></strong>.</li>\r\n<li><strong><u>Dyspepsia is very common; vomiting and diarrhoea</u></strong></li>\r\n<li><strong><u>Peptic ulcer</u></strong> may be activated.</li>\r\n<li><strong><u>Dryness and hyperpigmentation of skin</u></strong></li>\r\n<li>Other <strong><u>long-term effects</u></strong> are:\r\n<ul>\r\n<li><strong><em>Liver dysfunction and jaundice. </em></strong></li>\r\n<li><strong><em>Hyperglycaemia, precipitation of diabetes</em></strong></li>\r\n<li><strong><em>Hyperuricaemia and gout, </em></strong></li>\r\n<li><strong><em>Atrial arrhythmias.</em></strong></li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<p><strong><u>Niacin is contraindicated during pregnancy and in children</u></strong>.</p>\r\n<p><strong>Option D</strong>: The sustained-release formulation of niacin has less incidence of flushing versus that of the immediate release;</p>\r\n<p><strong>Key takeaway:</strong></p>\r\n<ul>\r\n<li><strong><em>Flushing associated with niacin is prostaglandin mediated</em></strong>; therefore, use of aspirin (a prostaglandin inhibitor) can help to minimize this adverse effect.</li>\r\n<li><strong><em><u>Laropiprant, </u></em></strong><strong><u>a prostanoid receptor inhibitor</u></strong>, is a specific antiflushing drug with no hypolipidaemic action of its own, that has been <strong>combined with nicotinic acid to minimize flushing.</strong></li>\r\n</ul>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Nifedipine</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Lisinopril</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Torsemide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56 year old male patient brought to medicine department with history of chronic stable angina and he was already on anti-anginal medications for the same. Now he complaints pedal edema, breathlessness and other symptoms of heart failure. Which of the following drug can increase longevity in this patient?</span></p>",
      "unique_key": "DT1293090",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293090,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong><em><u>ACE Inhibitors/Angiotensin Receptor Blockers</u></em></strong></li>\r\n<li>These <strong><em>drugs are indicated in all grade of Congestive heart failure</em></strong> unless contra-indicated. These can decrease mortality in CHF.</li>\r\n<li>These <strong><em>decrease the mortality via prevention and reversal of cardiac remodeling due to aldosterone (final mediator of remodeling).</em></strong></li>\r\n<li><strong><em>ACE inhibitors cause both arteriolar and venodilatation</em></strong> in <strong><em>Congestive heart failure</em></strong> patients; <strong><em>reduce afterload as well as preload on heart and improve all haemodynamic parameters</em></strong>.</li>\r\n<li>ACE inhibitors <strong><em>reduce episodes of decompensation, myocardial infarction and sudden death.</em></strong></li>\r\n<li>Long term benefits of ACE inhibitors accrue from <strong><em>withdrawal of Angiotensin II mediated ventricular hypertrophy, remodeling, accelerated myocyte apoptosis and fibrosis.</em></strong></li>\r\n<li>Indirect benefits occur due to <strong><em>reduction in sympathetic activation and aldosterone levels.</em></strong></li>\r\n<li>These drugs <em><u>decrease mortality</u></em> in <strong><em>Congestive heart failure</em></strong></li>\r\n</ul>\r\n<ol style=\"list-style-type: upper-alpha;\">\r\n<li><strong><em> Beta Blockers</em></strong></li>\r\n<li><strong><em> ACE inhibitors</em></strong></li>\r\n<li><strong><em> Angiotensin Receptor Blockers</em></strong></li>\r\n<li><strong><em> Aldosterone Antagonists</em></strong></li>\r\n</ol>\r\n<p><strong>Option A</strong>: Earlier <em>nifedipine </em>was used sublingually for hypertensive emergencies but now this practice has been banned due to <em>increased risk of MI and mortality</em>.</p>\r\n<p><strong>Option B</strong>: Digitalis/Digoxine is an inotropic agent that is indicated when heart is not able to pump the blood adequately</p>\r\n<p><strong>Option D</strong>: Torsemide is a loop diuretics. Main use of loop diuretics is to remove <em>the edema fluid </em>in renal, hepatic or cardiac diseases. These can be administered i.v. <em>for prompt relief of acute</em> <em>pulmonary edema </em>(due to vasodilatory action).</p>\r\n<p><strong>Key takeaway:</strong></p>\r\n<ul>\r\n<li>Long term benefits of ACE inhibitors accrue from <strong><em>withdrawal of Angiotensin II mediated ventricular hypertrophy, remodeling, accelerated myocyte apoptosis and fibrosis.</em></strong></li>\r\n</ul>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased levels of cGMP</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased binding of calcium to calmodulin</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased formation of IP3</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased myosin light-chain kinase activity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 59 year old woman taking an anti-anginal drug comes to medicine OPD with complains of chronic constipation despite appropriate dietary intake of fiber and fluids. The smooth muscle relaxation produced by her medication most likely results from which of the following signal transduction event?</span></p>",
      "unique_key": "DT1293092",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293092,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li>The Calcium channel blockers such as <strong><em>nifedipine &amp; Verapamil are the calcium channel blocker drugs</em></strong> <strong><em>that typically cause constipation</em></strong>, most likely because <u>they relax gastrointestinal smooth muscle.</u></li>\n<li>These <strong><em>drugs reduce calcium influx, thereby reducing formation of the calcium-calmodulin complex that increases myosin light-chain kinase activity.</em></strong>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122115a41254-a3b3-4835-b8e9-f4d9098f57ca.jpg\"></li>\n<li>Smooth muscles depolarize primarily by inward Ca2+ movement through voltage sensitive L-type channel.</li>\n<li>These Ca2+ ions trigger release of more Ca2+ ions from intracellular stores and together bring about <strong><em>excitation-contraction coupling through phosphorylation of myosin light chain </em></strong>as shown in the figure above.</li>\n<li>The <strong><em>Calcium channel blockers cause relaxation by decreasing intracellular availability of Ca2+.</em></strong></li>\n<li>They <u>markedly</u> <strong><em>relax arterioles but have mild effect on veins</em></strong>.</li>\n<li><em><u>Extravascular smooth muscle (bronchial, biliary, intestinal, vesical, uterine) is also relaxed.</u></em></li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<ul>\n<li>The Calcium channel blockers such as <strong><em>nifedipine &amp; Verapamil are the calcium channel blocker drugs that typically cause constipation</em></strong>, most likely because <u>they relax gastrointestinal smooth muscle.</u></li>\n</ul>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased left ventricular end-diastolic volume</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased blood flow in large epicardial vessels</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased heart rate</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased diastolic perfusion time</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old woman recently diagnosed with variant angina started treatment with Isosorbide mononitrate and diltiazem. Which amongst the following action is most likely mediated the therapeutic effect of nitrates in the patient's disease?</span></p>",
      "unique_key": "DT1293093",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293093,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Nitrates <strong><em>dilate large epicardial vessels, thus increasing epicardial blood flow</em></strong>.</li>\r\n<li>This action is the <strong><em>most important for the therapeutic effect of these drugs in variant angina, which is characterized by coronary spasm.</em></strong></li>\r\n<li><strong><em>Mechanism of relief of angina</em></strong></li>\r\n<li><strong><u>Variant angina</u></strong>\r\n<ul>\r\n<li>The <strong><em>relaxant effect on larger coronary vessels is the principal action</em></strong> of nitrates benefiting variant angina by <strong><em>counteracting coronary spasm</em></strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong><u>Classical angina</u></strong></li>\r\n<li>The <strong><em>primary effect is to reduce cardiac work by action on peripheral vasculature</em></strong>, though <strong><em>increased blood supply to ischaemic area</em></strong> may contribute.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241221882fa12d-cf18-4b28-9750-573b86b39eab.jpg\">\r\n<p><strong>Mechanism of action</strong> of nitrates in classical angina - &darr; Preload</p>\r\n<p><strong>Mechanism of action</strong> of nitrates in variant angina &rarr; Dilation of coronary arteries</p>\r\n<p><strong>Option A</strong>: By causing venous dilation, nitrates can cause a decrease, not an increase, of left ventricular end-diastolic volume.</p>\r\n<p><strong>Option C</strong>: Nitrates can <strong><em>cause reflex tachycardia</em></strong> and reflex increase in cardiac contractility, but these are detrimental, not therapeutic, effects in patients with angina.</p>\r\n<p><strong>Option D</strong>: Nitrates can decrease diastolic perfusion time (as a consequence of reflex tachycardia), but this is a detrimental effect in patients with angina.</p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li>Nitrates <strong><em>dilate large epicardial vessels, thus increasing epicardial blood flow</em></strong>. This action is the <strong><em>most important for the therapeutic effect of these drugs in variant angina, which is characterized by coronary spasm.</em></strong></li>\r\n</ul>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Isosorbide mononitrate</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Nitroglycerin</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Nifedipine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 46-year-old anxious man was brought to physician with complaints of insomnia, nightmares, fatigue, diminished libido, and blanching of the fingers when exposed to cold. The man, recently diagnosed with exertional angina, had been taking an anti-anginal drug for 1 month. Which of the following drug most likely caused the patient's symptoms?</span></p>",
      "unique_key": "DT1293095",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293095,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>All <strong><em>&beta; blockers benefit angina of effort</em></strong>.</li>\r\n<li>Taken on a regular schedule they <strong><em>Decrease frequency of attacks and increase exercise tolerance.</em></strong></li>\r\n<li><u>High doses, however, may worsen angina in some patients by increasing ventricular size and reducing coronary flow</u>.</li>\r\n<li>Beta blockers are <strong><u>not suitable for variant (vasospastic) angina</u></strong></li>\r\n<li><strong><em><u>Adverse effects of beta blockers</u></em></strong></li>\r\n<li><strong><em><u>Mnemonic [BALD FISH]</u></em></strong></li>\r\n</ul>\r\n<p><strong>B</strong>ronchoconstriction</p>\r\n<p><strong>B</strong>radycardia</p>\r\n<p><strong>A</strong>rrhythmia</p>\r\n<p><strong>L</strong>ethargy</p>\r\n<p><strong>D</strong>isturbed glucose metabolism</p>\r\n<p><strong>F</strong>atigue</p>\r\n<p><strong>I</strong>nsomnia</p>\r\n<p><strong>S</strong>exual dysfunction</p>\r\n<p><strong>H</strong>ypotension</p>\r\n<p><strong>Option B, C &amp; D</strong>: All of the above drugs are suitably used in acute as well as other forms of angina.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li><em>Propranolol is a non-selective b-blocker. It can cause vasoconstriction by antagonizing b2 mediated vasodilatation and by unopposed &alpha; actions. So it is not a suitable choice for any kind of angina. Selective b-blocker can be tried in some forms of angina.</em></li>\r\n</ul>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Nitroglycerin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old man complained to his physician of palpitations, facial flushing, and vertigo. The man had been sufferring from gastroesophageal reflux disease for 3 years. Two week earlier, he was diagnosed with exertional angina and started the prescribed therapy. Which of the following drugs most likely caused the patient's symptoms?</span></p>",
      "unique_key": "DT1293096",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293096,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The dose of <strong><em>nitroglycerin given to this patient was likely high, as the symptoms the patient is referring to are classic for nitrate toxicity</em></strong>.</p>\n<ul>\n<li><strong><u>Different nitrates </u></strong>\n<ul>\n<li>Glyceryl Trinitrate / Nitroglycerine [GTN/ NTG]</li>\n<li>Isosorbide Dinitrate [IDN]</li>\n<li>Isosorbide Mononitrate [IMN]</li>\n<li>Penta Erythrital Tetra Nitrate [PETN]</li>\n<li>Amyl Nitrite [AN]</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412212ca9ad01-4963-451b-8285-ce51f09fef68.jpg\">\n<ul>\n<li><strong><em>Nitrates should not be given with Sildenafil </em></strong><strong><em>[Risk of Severe hypotension</em></strong>]</li>\n<li><strong>Adverse effects </strong>These are mostly due to vasodilatation.</li>\n<li><strong><em>Mnemonic [MRF]</em></strong></li>\n</ul>\n<p><strong><em>M</em></strong><em>ethemoglobinemia </em></p>\n<p><strong><em>R</em></strong><em>ashes are rare (common with pentaerythritol tetranitrate)</em></p>\n<p><strong><em>F</em></strong><em>ullness in head, throbbing headache; </em></p>\n<p><strong><em>F</em></strong><em>lushing, weakness, sweating, palpitation, dizziness and fainting; these are due to postural hypotension</em></p>\n<p><strong>Option A, B, C</strong>: Beta-blockers such as propranolol, verapamil, and diltiazem tends to decrease heart rate, <strong>so palpitations are unlikely.</strong></p>\n<p><strong>Key Takeaway:</strong></p>\n<ul>\n<li><em>Flushing, weakness, sweating, <u>palpitation, dizziness and fainting</u>; these are due to <strong>postural hypotension produced by vasodilator actions of nitrates.</strong></em></li>\n</ul>",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}